Our Partners
We have partnered with several of the leading international Venture Capital Firms in the field and are growing our network
360ip
360ip® is an international investment, fund management, advisory services and technology commercialization company focused on leveraging the Company’s expertise, networks and proprietary tools/processes to identify and monetize technology-based opportunities, thereby creating significant value and the highest potential returns. 360ip® currently operates in Asia and North America.
Trans Pacific Technology Fund
Trans Pacific Technology Fund is a technology-driven venture capital fund, investing in innovative companies shaping the future of global business. TPTF works actively with the leadership of our portfolio companies from different regions of the world, supporting their growth
Venture Sourcing Program
We have partnered with one of our sponsors, TPTF, to launch a new initiative which incentivizes our members to identify potential investments: Venture Sourcing Program (VSP).
As part of the VSP, the VC Club will advise our Members how to create a presentation introducing the Member’s potential investment opportunity and then will coordinate with TPTF to provide feedback. If the potential investment introduced by a Member is selected by TPTF for investment, the VC Club has arranged for the Member to receive compensation.
We look for companies specifically in industries such as Biotech, Pharma, Healthtech, Insurtech, AI, Nanotechnology, Blockchain and IOT, with a focus on Europe, America, and the Asia-Pacific region. However, open to other fast-growing industries.
If your company is selected, this is also a great addition to your CV, showcasing your research skills.
Sector Focus
Venture Capital is often channeled into the fastest growing and most innovative technologies of the future. For example, TPTF invests in a wide range of industries from advanced materials, AI, biotechnology, healthcare, information technology and IoT.
At the St Andrews VC Club, we focus on a similar scope of high-growth industries which reflect the primary target sectors for start-up companies.
Case Study of a Typical VC Deal
The following is an example of a recent deal which was particularly interesting:
Industry's Insights
"Growth is never by mere chance; it is the result of forces working together."
Keep updated about our weekly to bi weekly Venture Capital Insights through our Facebook page
Speech analytics software is a current area of growing investment interest. Speech analytics software involves analysing recorded or live audio. One use for this is automated transcription. Out-of-the-box speech analytics software such as Google-Speech-to-Text can often be inaccurate and not scalable to analyse a large quantity of audio simultaneously. Another problem is that current speech analytics software are often made solely for certain languages, especially popular languages like English. This leaves room for scalable software utilising AI to provide a higher quantity of accurate transcriptions simultaneously as well as develop a wider language portfolio.
Speech transcription software is essential for many companies such as law firms which require a large amount of transcription or for countries that have a more diverse and unique language profile.
Speech Analytics Software
- David Erskine
Discounted Cash Flow (DCF)
- David Erskine
A common valuation method utilised by venture capital firms during due diligence of start-ups is Discounted Cash Flow (DCF) valuation. DCF provides a tangible value to the company. DCF uses a projection of future cash flows which is then discounted by a discount rate. As a result, this method provides a discounted cash flow valuation of a company.
If you’d like to learn more about DCF valuation consider reading this article from Street of Walls: Discounted cash flow analysis
One area of investment research at TPTF (our partner company) is microbiome companies in Asia. A microbiome is an ecosystem of microorganisms. Microbiomes are an essential component of human health. One particularly interesting human microbiome is the gut microbiome which recent research is showing may play a role in diseases such as Alzheimer’s, and Autism. Due to this, microbiome products are an area of interest for venture capital funding. One of TPTF’s portfolio companies is a microbiome biotech company called Finch Therapeutics which is currently focusing on C.difficile, and Autism.
Read more about microbiome’s potential here: Mining the Microbiome
Microbiome
- David Erskine